Heidelberg Pharma to Present at the Upcoming Virtual European Biotech Investor Day 2020
Heidelberg Pharma AG today announced that Prof Andreas Pahl, Chief Scientific Officer, plans to present an overview of the company at the upcoming Virtual European Biotech Investor Day 2020, taking place on 25th June 2020 and hosted by Solebury Trout, Goodwin, Deutsche Bank and Nasdaq.